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Abstract 63 
This study investigated whether ischemic preconditioning in a trained population affected 64 
repeated sprint performance.  A secondary aim was to assess responses according to gender. 65 
Sixteen (nine females and seven males) well trained team sport athletes took part in a 66 
randomised crossover study design.  Participants underwent an ischemic preconditioning and 67 
placebo treatment involving three periods of 5 min occlusion applied unilaterally (3 x 5 min 68 
occlusion to each leg) at either 220 mmHg or 50 mmHg respectively.  Each period of 69 
occlusion was followed by 5 min reperfusion.  Following treatment 5 x 6 s maximal effort 70 
sprints were undertaken on a cycle ergometer against 7.5 % body mass, each interspersed by 71 
24 s recovery.  Measured parameters included peak power, total power, percentage 72 
decrement, post exercise blood lactate and ratings of perceived exertion. No within subject 73 
main effect for ischemic preconditioning was observed, neither was there an interaction effect 74 
with gender.  Effect sizes were trivial (ES<0.2) with the exception of a  moderate (ES<1.2) 75 
change in post exercise blood lactate in the female cohort (1.6 ± 0.4 mmol-1 lower following 76 
IPC). Results suggest no benefit to team sport players in utilising ischemic preconditioning as 77 
a means of enhancing repeated sprint performance.  A lower blood lactate response in female 78 
participants following ischemic preconditioning may suggest improved blood flow through 79 
vasodilation.  80 
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Introduction 99 
Since early research investigating the effect of ischemic preconditioning on the myocardium 100 
the beneficial effect of the treatment has been observed in different tissues within the body, 101 
including skeletal muscle (de Groot, Thijssen, Sanchez, Ellenkamp, Hopman, 2010; Crisafulli 102 
et al., 2011; Beaven, Cook, Kilduff, Drawer, Gill, 2012; Jean-St-Michael et al., 2011).  103 
Research investigating the effect of ischemic preconditioning on exercise has included 104 
measures of aerobic capacity (de Groot et al., 2010; Crisafulli et al., 2011), speed (Gibson, 105 
White, Neish, Murray, 2013) and recovery following strength and power tasks (Beaven et al., 106 
2012). Data from these studies is equivocal with the suggestion that a pattern of responders 107 
and non-responders may exist and that the intervention may be less effective in female 108 
populations (Beaven et al., 2012; Gibson et al., 2013). 109 
The ability of ischemic preconditioning to exert a beneficial effect on exercise and recovery 110 
thereafter appears to be dependent on metabolites, including bradykinin, opioids and 111 
adenosine, reaching a critical level (Downey, Davis, Cohen, 2007).  Inhibition of one of these 112 
metabolites removed the beneficial effect of a single bout of ischemic preconditioning 113 
suggesting the existence of a threshold below which occlusion may prove ineffective (Goto et 114 
al. 1995).  Adopting multiple episodes of ischemic preconditioning has been advocated 115 
within the literature to ensure such a threshold is met (de Groot et al., 2010, Crisafulli et al., 116 
2011, Jean-St-Michael et al., 2011).  117 
Much of the research to date has focused on the usefulness of ischemic preconditioning on 118 
exercise tasks of an endurance nature with positive effects reported for total work, power, 119 
exercise time (Crisafulli et al., 2011) and (de Groot et al., 2010).  The effect of 120 
ischemic preconditioning on activities of a shorter and more anaerobic nature is less clear: a 121 
significant improvement has been reported in elite level swimmers over a distance of 100m 122 
(Jean-St-Michael et al., 2011) whilst no improvement was noted when cyclists used the 123 
intervention prior to performing supra-maximal efforts (Crisafulli et al., 2011).  It should be 124 
noted however that in both these studies exercise time was in excess of 60s, considerably 125 
longer than typical anaerobic efforts observed in team sport environments (Spender, Bishop, 126 
Dawson & Goodman, 2005).  When utilised prior to land based sprint activities no effect was 127 
reported (Gibson et al., 2013) however the intervention was found to be beneficial on 128 
measures of acute and chronic recovery when used between tasks requiring maximal force 129 
generation (Beaven et al., 2012).  This may in part be due to enhanced muscle recruitment via 130 
a desensitizing of the afferent groups III and IV, increased neural drive and force output 131 
(Noakes, 2011) Interestingly, it has been suggested that ischemic preconditioning is less 132 
beneficial in female populations (Beaven et al., 2012; Gibson et al., 2013) 133 
Whilst a number of individual events are characterised by short but intense single efforts, 134 
team invasion sports require the performance of multiple bouts of maximal and at times 135 
supra-maximal activity (Spencer et al., 2005; Gabbett, 2012; Dwyer & Gabbett, 2012; 136 
Impellizeri et al., 2006; Gabbett, 2009).  The importance of these repeated sprint efforts to 137 
successful performance has been illustrated within rugby league (Gabbett, 2012).  Given that 138 
ischemic preconditioning has been shown to exert a beneficial effect on performance in high 139 
intensity tasks when administered 45 minutes before competition (Jean-St-Michael et al., 140 
2011) its use within the warm up prior to team sports would seem plausible.  Ischemic 141 
preconditioning has been evidenced to enhance vasodilation, oxygen delivery and ATP 142 
sparing (Beaven et al., 2012; Liu et al., 1991; Jennings, Sebbag, Schwartz, Crago & Reimer, 143 
2001), adaptations similar to those that could be expected following endurance training.  144 
With this in mind a positive effect on repeated sprint activities may be expected given the 145 
max2OV
large aerobic component that exists in exercise of this nature (Dupont, McCall, Prieur, Millet 146 
& Berthoin, 2013; Bucheit & Laursen, 2013).  The current investigation is designed to assess 147 
whether ischemic preconditioning exerts a beneficial effect when used prior to repeated sprint 148 
activity performed on a cycle ergometer.  Given the large aerobic component that is 149 
associated with exercise of this nature it is hypothesised that enhanced oxygen delivery, 150 
facilitated through adenosine mediated vasodilation and/or ATP sparing, will provide a 151 
beneficial effect on performance.  A secondary aim is to compare responses between gender 152 
groups to further investigate the assertion that ischemic preconditioning may be less suitable 153 
for female populations (Beaven et al., 2012; Gibson et al., 2013) 154 
Methods 155 
Participants and design 156 
Sixteen participants (7 males and 9 females) volunteered to take part in the study, all with a 157 
recognised competition history within the invasion sports of Soccer, Field Hockey and Rugby 158 
Union.  Mean age, stature and body mass are presented in table I.  All participants signed an 159 
informed consent document and the study received institutional ethical approval conforming 160 
to the code of ethics of the World Medical Association (Declaration of Helsinki). 161 
A counterbalanced randomised crossover design was used to assess the impact of a brief 162 
period of remote ischemic preconditioning on repeated sprint performance under two separate 163 
conditions, experimental and placebo.  All participants undertook a prior control with no 164 
treatment.  In both placebo and ischemic preconditioning trials participants were fitted with a 165 
blood pressure cuff positioned around the upper thigh and inflated to 50 mmHg or 220 166 
mmHg respectively.  Following treatment participants followed a standardised warm up 167 
followed by 5 x 6 s sprints against an external load of 7.5 % body mass. Measured variables 168 
were peak power, relative peak power (Watts per kilogram body mass), total power, 169 
percentage decrement, post assessment blood lactate and ratings of perceived exertion (RPE).  170 
***INSERT TABLE 1 NEAR HERE*** 171 
Baseline assessment and control 172 
All participants were required to visit the laboratory on three separate occasions each no more 173 
than seven days apart for the collection of control, placebo and experimental data.  On their 174 
first visit participants’ age, stature and body mass were recorded along with a measure of 175 
resting blood pressure (Omron RX-3, Kyoto – Japan).  Any participants presenting with a 176 
blood pressure higher than 140/100 mmHg (systolic/diastolic) were precluded from taking 177 
part in the study.  These guidelines were in line with ethical approval of the study. Prior to 178 
data collection the cycle ergometer (MonarkErgomedic 814c, Stockholm, Sweden) was 179 
calibrated according to the manufacturers guidelines and configured to suit the participants 180 
preferred cycling position.  Participants completed a standardised warm up consisting of five 181 
minutes stationary cycling at 60 rpm and against 1kg of external resistance.  This was 182 
followed by two 3s sprints separated by 60 s to habituate themselves with the requirements of 183 
the assessment.  The repeated sprint assessment required the performance of 5 x 6 s sprints 184 
against 7.5 % of body mass, each separated by a recovery period of 24 s, a protocol used 185 
previously in team sport athletes (Blee, Goodman, Dawson & Stapff, 1999; Bishop, Spencer, 186 
Duffield & Lawrence, 2001).  This protocol was chosen to limit the impact of pacing and 187 
provide a sufficient number of sprints for the accurate and reliable assessment of peak power 188 
and percentage decrement (Hachana, Attia, Nassib & Shephard, 2012).  Blood lactate 189 
samples were collected three minutes post the fifth and final sprint using a Lactate Pro 190 
analyser (ArkrayInc, Kyoto, Japan. CV 5.66%).  RPE data was collected following each of 191 
the five sprints. Data from the repeated sprint protocol was collected and analysed using 192 
specific software (Cranlea Wingate Software version 3).  Following the collection of control 193 
data all participants underwent both placebo and experimental conditions in a randomised 194 
counterbalanced fashion. 195 
Placebo trial 196 
On arrival at the laboratory participants had their blood pressure measured as described above 197 
to screen for any contraindications to the experimental procedure.  Participants were then 198 
instructed to adopt a semi-recumbent position on a medical plinth with both legs outstretched.  199 
A blood pressure cuff (Boso-roid I aneroid sphygmomanometer, Bosch and Son, Germany) 200 
was positioned around the upper thigh, distal to the inguinal fold.  For placebo treatment the 201 
cuff was inflated by hand to 50mmHg.  Each leg was exposed to 5 min of pressure followed 202 
by 5min of reperfusion for three consecutive cycles eliciting a total treatment time of 30 min.  203 
During reperfusion the contralateral leg was fitted with the cuff and inflated to 50 mmHg in 204 
accordance with the protocol for ischemic preconditioning administration described 205 
elsewhere (Gibson et al., 2013).  During the treatment participants were asked at regular 206 
intervals (every minute) to confirm they were able to continue with the protocol.  Any 207 
participant indicating light headedness, nausea or discomfort had the pressure cuff removed 208 
and were omitted from the study (n = 0).  Following the final 5 min of reperfusion the 209 
participant was supported whilst they stepped down from the plinth and given a moment to 210 
ensure they were steady on their feet before commencing the standardised warm up detailed 211 
above.  The time delay between removing the pressure cuff and commencing the warm up 212 
was five minutes. 213 
Ischemic preconditioning treatment 214 
The ischemic preconditioning treatment followed an identical format to that of the protocol as 215 
described above however the blood pressure cuff was inflated to 220 mmHg which has been 216 
shown to elicit ischemia by occluding arterial blood flow to the lower legs (Koojiman et al., 217 
2008). 218 
Statistical analysis 219 
Data was checked for homogeneity of variance using Lavene’s test and did not violate the 220 
assumption of sphericity using Mauchly’s test.  All results were non-significant (P<0.05) and 221 
as such deemed appropriate for parametric analysis.  Data were analysed using SPSS for 222 
windows (PASW statistics 17.0) and a 3 x 2 mixed factorial ANOVA with significance 223 
calculated at P<0.05.  Due to the practical nature of the investigation effect sizes (Cohen’s d) 224 
were also used.  Effect sizes of <0.2, <0.6, <1.2, <2.0 and >2 were considered trivial, small, 225 
moderate, large and very large respectively (Hopkins, Marshall, Batterham & Hanin, 2009). 226 
Results 227 
Table I details the physical characteristics of participants included in the study as a pooled 228 
cohort and separated by gender groups.  Table II details means ± SD’s for performance 229 
variables calculated during the repeated sprint protocol along with corresponding effect sizes 230 
comparing control with ischemic preconditioning trials.  No significant main effect or 231 
interaction with gender was observed for occlusion on peak power or relative peak power 232 
(P>0.05) as shown in figure 1. Calculated effect sizes were classified as trivial (ES<0.2) for 233 
peak power, total power and relative peak power.  Within the female cohort a small effect 234 
size was detected for percentage decrement whilst for the blood lactate response effect sizes 235 
of small and moderate magnitude were calculated for the male and female cohort respectively 236 
as shown in figure 2. 237 
***INSERT TABLE II NEAR HERE*** 238 
***INSERT FIGURE I NEAR HERE*** 239 
***INSERT FIGURE II NEAR HERE*** 240 
Discussion 241 
Data collected in the current investigation suggest ischemic preconditioning to exert neither a 242 
beneficial nor deleterious effect on absolute and relative peak power, total power or 243 
percentage decrement during a repeated sprint protocol.  Unlike previously reported data 244 
(Beaven et al., 2012; Gibson et al., 2013) there appears to be no difference in response to the 245 
intervention when compared by gender group with the exception of post exercise blood 246 
lactate. Results would suggest that for events requiring short (<6 s) maximal efforts ischemic 247 
preconditioning is not a suitable pre exercise intervention for performance enhancement.  The 248 
finding that post exercise blood lactate levels may be reduced, especially in a female cohort, 249 
combined with non-significant changes in total power and percentage decrement warrants 250 
further investigation into the effect of ischemic preconditioning on activities requiring 251 
repeated forceful yet sub-maximal efforts, such as those occurring in team sports (Spencer et 252 
al., 2005; Gabbett, 2012; Dwyer & Gabbett, 2012; Impellizeri et al., 2006; Gabbett, 2012).  253 
The ability to produce similar amounts of work whilst attenuating the production of lactate 254 
and/or augmenting its clearance may suggest the intervention to facilitate a greater 255 
contribution from aerobic pathways and the sparing of ATP generated via glycolysis (Bailey 256 
et al., 2012). 257 
Equivocal results are apparent in response to power output following ischemic 258 
preconditioning administration.  When used as a recovery modality following activities 259 
requiring high power output ischemic preconditioning was shown to attenuate reductions in 260 
performance, both acutely and chronically (Beaven et al, 2012).  In a study conducted with 261 
international level swimmers the intervention was shown to improve performance by 0.7 s, a 262 
change paralleled with an increased stroke count.  This change may be interpreted as being 263 
the result of less force exerted per stroke (Jean-St-Michael, 2011).  The event duration (~60 264 
s) may have provided sufficient time for any decrement in initial peak power following 265 
ischemic preconditioning administration to be compensated for by a higher sustained average 266 
power in the latter stages of the race.  It should be noted that in the present study ischemic 267 
preconditioning exerted no significant effect on average, total or peak power.  In cyclists 268 
exercising supra-maximally for approximately 120 s no beneficial effect of ischemic 269 
preconditioning was realised in terms of exercise time or power output (Crisafulli et al., 270 
2011). In studies examining the effect of ischemic preconditioning on swimmers and cyclists 271 
however exercise duration was substantially longer than that which has been reported for 272 
team sports (Spencer et al., 2005), a sporting population from which the current cohort was 273 
drawn. Considering the present study’s findings and those reported when ischemic 274 
preconditioning was used prior to short land based sprinting (<5 s) (Gibson et al., 2013) there 275 
appears to be evidence that would support the existence of a threshold in exercise duration 276 
below which the intervention has no effect on performance.  277 
A mechanism postulated for the beneficial effect of ischemic preconditioning on exercise is 278 
increased blood flow and oxygen delivery to the working musculature via adenosine 279 
mediated vasodilation (Beaven et al., 2012; Liu, 1991).  There is also evidence of ATP 280 
preservation, albeit in canine models (Jennings et al., 2001).  In the current investigation no 281 
changes in performance following ischemic preconditioning with respect to percentage 282 
decrement were reported however moderate effect sizes were measured for post exercise 283 
blood lactate in the female cohort with lower values reported following IPC.  Lower blood 284 
lactate levels following exercise preceded by ischemic preconditioning have been reported 285 
elsewhere (Bailey et al., 2012).  Following 5 x 3 minute stages of incremental treadmill 286 
running ranging from 10 to 14 km.h-1 blood lactate was observed to be 1.07 ± 0.11 mmol-1 287 
lower when ischemic preconditioning preceded exercise.  In the present study repeated 288 
sprints preceded by ischemic preconditioning were shown to illicit a blood lactate response 289 
1.6 ± 0.4 mmol-1 lower than control within the female cohort and a corresponding moderate 290 
effect size. This reduction was paralleled by non-significant changes in peak power, total 291 
power and percentage decrement.  It is suggested that future research includes a greater 292 
number of sampling points to more fully explain lactate kinetics following exercise preceded 293 
by ischemic preconditioning.  294 
Whilst improvements in aerobic capacity have been associated with reduced blood lactate 295 
following sub-maximal exercise of a given workload (Lorenzo, Minson, Babb & Halliwell, 296 
2011) this mechanism is unlikely to explain changes in hematology during the present study.  297 
An alternative hypothesisis that ischemic preconditioning mimics some of the chronic 298 
changes associated with training and its associated improvements in aerobic capacity may be 299 
postulated.  These include but are possibly not limited to, vasodilation and the associated 300 
increases in blood flow that facilitate energy provision via aerobic pathways, sparing of ATP 301 
derived from anaerobic glycolytic pathways and potential augmentation of blood lactate 302 
clearance.  Previous results have shown that the provision of energy via aerobic pathways 303 
increases during repeated sprint exercise to compensate for the reduction in glycolysis 304 
(Bailey et al., 2012).  A strong relationship has also been shown between repeated sprint 305 
performance and aerobic capacity (Dupont et al., 2010; Bishop et al., 2004) characterised by 306 
an enhanced ability for energy provision via increased capilliarisation, blood flow and 307 
mitochondrial density.  Indeed it was augmentation of blood flow which was suggested as a 308 
potential mechanism for ischemic preconditioning providing a beneficial stimulus when used 309 
as a recovery modality following tasks requiring maximal force generation (Beaven et al., 310 
2012). Reductions in blood lactate following the use of ischemic preconditioning may be a 311 
result of enhanced energy provision via aerobic pathways, ATP sparing and/or enhanced 312 
oxidation and clearance rates.  Such mechanisms would lend support to the contention that 313 
during repeated sprint activities where energy derived from anaerobic processes is 314 
compromised as a result of intensity, duration or insufficient between effort recovery, 315 
ischemic preconditioning may be beneficial to performance. 316 
It was hypothesised that ischemic preconditioning would result in a greater decrement in 317 
performance within the female cohort, something that was not evident in the results.  318 
Previous studies have shown the intervention to negatively affect performance in female 319 
athletes when used prior to land based sprinting activities and as a recovery tool following 320 
strength and power activities (Beaven et al., 2012; Gibson et al., 2013).  Individual variations 321 
in thigh circumference, muscle mass and limb composition and the corresponding level of 322 
occlusion caused at an absolute pressure of 220 mmHg (Dempsey & Wagner, 1999) have 323 
been cited as potential causes of this discrepancy, along with the perception of discomfort 324 
associated with the intervention.  RPE data collected in the present study would not support 325 
the contention that a greater perception of effort and/or discomfort was associated with 326 
ischemic preconditioning in male or female participants.  It is acknowledged however that 327 
given the relatively low participant numbers in the present study drawing firm conclusions 328 
regarding differences that may exist between gender is difficult. 329 
Time motion analysis in team sports has suggested mean sprint durations to be between 2-3 s 330 
for elite level Soccer, Field Hockey and Australian Rules Football rising to 4.1 ± 1.1 s when 331 
mean maximal sprint duration is considered (Spencer et al., 2005).  As such the protocol in 332 
the present study characterised by 5 x 6 s sprints has been suggested to be representative of 333 
field based invasion game activity. For sports that incorporate short (<1 s) accelerative efforts 334 
requiring high force output results from the present study would suggest ischemic 335 
preconditioning to be an inappropriate pre exercise intervention.  If however the sport is more 336 
reliant on running sprints (Impellizeri et al., 2006) characterised by high running speeds over 337 
longer durations and potentially less forceful accelerations (Gabbett, 2012), the use of 338 
ischemic preconditioning may be warranted given non-significant changes in percentage 339 
decrement and lower post exercise blood lactate levels in the female cohort. Future research 340 
should focus on investigating the effectiveness of IPC as a precursor to land based repeated 341 
sprint activities and/or sport specific simulation protocols (Twist & Sykes, 2011)  342 
Conclusion  343 
Ischemic preconditioning exhibited no beneficial effect on markers of performance associated 344 
with repeated sprinting characterised by 5 x 6 s efforts, including total power, peak power 345 
and relative peak power. Additionally there appears to be no difference in response between 346 
gender groups following the intervention as has been reported for single sprint activity and 347 
recovery.  Interestingly however a  moderate reduction in post exercise blood lactate 348 
following ischemic preconditioning in the female cohort was observed.  This finding may 349 
suggest that for repeated sprint protocols of a longer duration, or those involving actions that 350 
more closely mimic the demands of team sports, such as collisions or changes of direction 351 
ischemic preconditioning may be beneficial to markers of performance.   352 
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 496 
Table 1. Means ± SD for physical characteristics of participants as a pooled cohort and 497 
separated by gender. 498 
 499 
Physical characteristic Participants (n = 16) Female (n = 9) Males (n = 7) 
Age (years) 24.1 ± 2.6 24.0 ± 3.71 24.2 ± 1.6 
Stature (cm) 174.0 ± 6.1 171.1 ± 4.4 177.6 ± 6.2 
Mass (kg) 73.7 ± 11.8 67.6 ± 7.1 81.4 ± 12.5 
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 540 
Table 2. Means ± SD for peak power (PP), peak power adjusted for body mass (RPP), total power (TP), percentage decrement (%Dec) and delta 541 
rating of perceived exertion (RPE) along with corresponding effect sizes for control, placebo and ischemic preconditioning repeated sprint trials.  542 
Effect sizes correspond to the change between control and ischemic preconditioning trials.  Data reported for all participants and by gender 543 
group. 544 
 545 
Effect sizes of <0.2, <0.6, <1.2, <2.0 and >2 were considered trivial, small, moderate, large and very large respectively. 546 
 547 
 548 
 549 
. Pooled data (n = 16) Females (n = 9) Males (n = 7) 
 Control Placebo IPC ES Control Placebo IPC ES Control Placebo IPC ES 
PP (W) 1583.2 ± 368.6 1611.7 ± 461.7 1577.4 ± 374.1 0.02 
 
1360.4 ± 247.0 1319.9 ± 102.3 1353 ± 184.1 0.03 1869.7 ± 297.5 1987.0 ± 476.4 1865.6 ± 363.9 0.01 
RPP 
(W.kg) 
21.4 ± 3.6 21.7 ± 4.3 21.3 ± 2.9 0.04 20.1 ± 2.7 19.8 ± 2.7 20.1 ± 2.0 0.01 23.1 ± 4.1 24.2 ± 4.7 22.9 ± 3.1 0.07 
TP (W) 6748.6 ± 1413.6 6842 ± 1712.0 6668.6 ± 1364.0 0.06 
 
5883.5 ± 895.0 5707.3 ± 489.2 5788.3 ± 630.1 0.12 7860.7 ± 1167.1 8301.0 ± 1611.5 7800.2 ± 1211.0 0.05 
%Dec 14.1 ± 5.3 14.4 ± 5.2 14.8 ± 4.3 0.15 
 
12.8 ± 6.2 13.4 ± 6 14.1 ± 4.4 0.23 15.8 ± 3.8 15.7 ± 3.9 15.8 ± 4.4 0.01 
Bla 
(mmol-1) 
9.3 ± 2.1 9.0 ± 2.6 8.2 ± 2.3 0.51 9.0 ± 2.4 8.8 ± 2.4 7.4 ± 2.0 0.72 9.7 ± 1.9 9.4 ± 2.9 9.2 ± 2.3 0.25 
Delta 
RPE 
4.6 ± 2.3 5.0 ± 2.9 5.0 ± 2.3 0.19 3.8 ± 1.6 4.2 ± 1.4 4.2 ± 1.8 0.26 5.6 ± 2.8 6.0 ± 2.9 6.0 ± 3.7 0.18 
Figure 1.  Mean ± SD for relative peak power (RPP) and percentage decrement (%Dec) 550 
across 5 x 6 s sprints on a cycle ergometer against 7.5% of body mass.   551 
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 578 
Figure 2.  Mean ± SD  for the blood lactate (Bla) response following baseline ischemic 579 
preconditioning and placebo trials for all participants and separated by gender.  * denotes a  580 
moderate effect size for differences in Bla response within female participants following 581 
ischemic preconditioning compared to baseline trials  582 
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